Bio-Rad Laboratories, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 592.1M | 693.2M | 653.0M | 651.6M | 585.4M | 667.5M | 649.7M | 638.5M |
| Cost of Goods Sold | 282.7M | 348.0M | 309.6M | 306.3M | 279.4M | 325.6M | 293.8M | 282.8M |
| Gross Profit | 309.4M | 345.2M | 343.4M | 345.3M | 306.0M | 341.9M | 355.9M | 355.1M |
| R&D Expenses | 62.9M | 65.7M | 71.3M | 60.5M | 73.5M | 79.6M | 91.0M | 59.3M |
| Operating Expenses | 275.3M | 282.3M | 278.1M | 268.2M | 282.3M | 283.6M | 291.4M | 253.6M |
| Operating Income | 34.1M | 61.9M | 66.4M | 77.1M | 23.7M | 58.3M | 64.5M | 101.5M |
| Other Income / Gains | -723.9M | 867.3M | -497.5M | 336.9M | 59.7M | -967.2M | 797.2M | -2.89B |
| Net Income | -527.1M | 720.0M | -341.9M | 317.8M | 64.0M | -715.8M | 653.2M | -2.17B |
| EPS (Diluted) | -19.55 | 26.69 | -12.70 | 11.67 | 2.29 | -25.57 | 23.37 | -76.26 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.523 | 0.498 | 0.526 | 0.53 | 0.523 | 0.512 | 0.548 | 0.556 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 212.4M | 216.6M | 206.8M | 207.7M | 208.8M | 204.0M | 200.4M | 196.1M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | -42K | 0 | -1.8M |
| Cost And Expenses | 558.0M | 630.7M | 587.7M | 574.5M | 561.7M | 609.1M | 585.3M | 538.2M |
| Interest Income | 21.0M | 31.0M | 13.7M | 14.7M | 36.2M | 15.9M | 15.5M | 16.6M |
| Interest Expense | 12.3M | 12.1M | 12.3M | 12.6M | 12.0M | 12.2M | 12.2M | 12.3M |
| Depreciation And Amortization | 40.9M | 52.4M | 54.2M | 50.6M | 38.1M | 49.3M | 49.1M | 46.6M |
| Ebitda | -636.6M | 993.7M | -364.6M | 477.2M | 133.5M | -847.4M | 922.9M | -2.73B |
| Ebitdaratio | -1.075 | 1.433 | -0.558 | 0.732 | 0.228 | -1.27 | 1.42 | -4.272 |
| Operating Income Ratio | 0.058 | 0.089 | 0.102 | 0.118 | 0.04 | 0.087 | 0.099 | 0.159 |
| Income Before Tax | -689.8M | 929.2M | -431.1M | 414.0M | 83.4M | -908.9M | 861.6M | -2.79B |
| Income Before Tax Ratio | -1.165 | 1.34 | -0.66 | 0.635 | 0.142 | -1.362 | 1.326 | -4.364 |
| Income Tax Expense | -162.7M | 209.2M | -89.2M | 96.2M | 19.4M | -193.1M | 208.4M | -620.8M |
| Net Income Ratio | -0.89 | 1.039 | -0.524 | 0.488 | 0.109 | -1.072 | 1.005 | -3.392 |
| Epsdiluted | -19.55 | 26.65 | -12.70 | 11.67 | 2.29 | -25.57 | 23.34 | -76.26 |
| Weighted Average Shs Out | 27.0M | 27.0M | 26.9M | 27.2M | 27.9M | 28.0M | 27.9M | 28.4M |
| Weighted Average Shs Out Dil | 27.0M | 27.0M | 26.9M | 27.2M | 28.0M | 28.0M | 28.0M | 28.4M |